Literature DB >> 26310534

Transanal total mesorectal excision for rectal cancer: a preliminary report.

Liang Kang1, Wen-Hao Chen1, Shuang-Ling Luo1, Yan-Xin Luo1, Zhi-Hua Liu1, Mei-Jin Huang1, Jian-Ping Wang2.   

Abstract

BACKGROUND: Currently, the majority cases of the novel down-to-up transanal total mesorectal excision (TaTME) were performed in a hybrid approach with conventional laparoscopic assistance because of less operative difficulty. However, although cases are limited, the successes of TaTME in a pure approach (without laparoscopic assistance) indicate that the costly and less mini-invasive hybrid TaTME could be potentially avoided.
METHODS: In the present single institutional, prospective study, we attempted to demonstrate the safety and feasibility of this approach in rectal cancer by evaluating the short-term results of our first 20 TaTME cases. For the majority of cases, we adopted a strategy that laparoscopic assistance was not introduced unless it was required during the planned pure TaTME procedure.
RESULTS: A total of 20 patients (12 males and 8 females) were analyzed in this study, including 11 cases (55 %) of pure TaTME and 9 cases (45 %) of hybrid TaTME. Overall, the median operative time was 200 min (range 70-420), along with a median estimated blood loss of 50 ml (range 20-800). Morbidity rate was 20 % (one urethral injury, two urinary retentions, one anastomotic hemorrhage and one mild anastomotic leak). The median number of harvested lymph nodes was 12 (range 1-20). All specimens were intact in mesorectum without positive distal and circumferential resection margins. Among the 15 patients who were preoperatively scheduled to undertake pure TaTME, four patients (26.7 %) required converting to laparoscopic assistance. Moreover, among these 15 patients, the results of the comparative analysis between female and male subgroups favor the former, suggesting easier operation in them.
CONCLUSION: This preliminary study demonstrates that TaTME in rectal cancer is safe and feasible. The strategy of not introducing laparoscopic assistance unless it is required while performing the planned pTaTME should be cautiously explored. Further studies with larger sample size and longer follow-up are warranted.

Entities:  

Keywords:  Laparoscopic assistance; NOTES; Rectal cancer; TME; Transanal

Mesh:

Year:  2015        PMID: 26310534     DOI: 10.1007/s00464-015-4521-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Transanal Total Mesorectal Excision: Will It Be A Valid Alternative in Rectal Cancer Surgery?

Authors:  Wen-Hao Chen; Shuang-Ling Luo; Liang Kang
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

2.  Complications of transvaginal natural orifice transluminal endoscopic surgery: a series of 102 patients.

Authors:  Stephanie G Wood; Lucian Panait; Andrew J Duffy; Robert L Bell; Kurt E Roberts
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

3.  Minilaparoscopy-assisted transrectal low anterior resection (LAR): a preliminary study.

Authors:  Antonio M Lacy; Cedric Adelsdorfer; Salvadora Delgado; Patricia Sylla; David W Rattner
Journal:  Surg Endosc       Date:  2012-07-18       Impact factor: 4.584

Review 4.  Laparoscopy for rectal cancer is oncologically adequate: a systematic review and meta-analysis of the literature.

Authors:  Alberto Arezzo; Roberto Passera; Alessandro Salvai; Simone Arolfo; Marco Ettore Allaix; Guido Schwarzer; Mario Morino
Journal:  Surg Endosc       Date:  2014-07-10       Impact factor: 4.584

5.  Transanal endoscopic proctectomy and nerve injury risk: bottom to top surgical anatomy, key points.

Authors:  M M Bertrand; P E Colombo; B Alsaid; M Prudhomme; P Rouanet
Journal:  Dis Colon Rectum       Date:  2014-09       Impact factor: 4.585

6.  Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery.

Authors:  María Fernández-Hevia; Salvadora Delgado; Antoni Castells; Marta Tasende; Dulce Momblan; Gabriel Díaz del Gobbo; Borja DeLacy; Jaume Balust; Antonio M Lacy
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

7.  Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer.

Authors:  H Zhang; Y-S Zhang; X-W Jin; M-Z Li; J-S Fan; Z-H Yang
Journal:  Tech Coloproctol       Date:  2012-08-31       Impact factor: 3.781

8.  Dynamic article: transanal rectal excision: a pilot study.

Authors:  Albert M Wolthuis; Anthony de Buck van Overstraeten; André D'Hoore
Journal:  Dis Colon Rectum       Date:  2014-01       Impact factor: 4.585

9.  No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery.

Authors:  Joël Leroy; Brian Donncha Barry; Armando Melani; Didier Mutter; Jacques Marescaux
Journal:  JAMA Surg       Date:  2013-03       Impact factor: 14.766

10.  NOTES total mesorectal excision (TME) for patients with rectal neoplasia: a preliminary experience.

Authors:  E Chouillard; E Chahine; G Khoury; B Vinson-Bonnet; A Gumbs; D Azoulay; E Abdalla
Journal:  Surg Endosc       Date:  2014-05-31       Impact factor: 4.584

View more
  8 in total

Review 1.  Transanal total mesorectal excision for rectal cancer: hype or new hope?

Authors:  Chien-Chih Chen; Yi-Ling Lai; Andy Yi-Ming Cheng; Chun-Ho Chu; I-Ping Huang; Shung-Haur Yang
Journal:  J Gastrointest Oncol       Date:  2019-12

2.  Transanal total mesorectal excision as a surgical procedure for diffuse cavernous hemangioma of the rectum: A case report.

Authors:  Xian-Rui Wu; Wei-Wen Liang; Xing-Wei Zhang; Liang Kang; Ping Lan
Journal:  Int J Surg Case Rep       Date:  2017-08-10

Review 3.  Recent advances in the management of rectal cancer: No surgery, minimal surgery or minimally invasive surgery.

Authors:  Joseph M Plummer; Pierre-Anthony Leake; Matthew R Albert
Journal:  World J Gastrointest Surg       Date:  2017-06-27

4.  Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum.

Authors:  Ziwei Zeng; Xianrui Wu; Junji Chen; Shuangling Luo; Yujie Hou; Liang Kang
Journal:  Gastroenterol Res Pract       Date:  2019-06-19       Impact factor: 2.260

5.  Transanal total mesorectal excision for rectal cancer: a multicentric cohort study.

Authors:  Liang Kang; Yuan-Guang Chen; Hao Zhang; Hong-Yu Zhang; Guo-Le Lin; Ying-Chi Yang; Wen-Hao Chen; Shuang-Ling Luo; Ning Chen; Wei-Dong Tong; Zhan-Long Shen; De-Hai Xiong; Yi Xiao; Zhong-Tao Zhang; Jian-Ping Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-11-08

6.  Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocol.

Authors:  Liang Kang; Ziwei Zeng; Shuangling Luo; Hong Zhang; Quan Wang; Mingyang Ren; Miao Wu; Weidong Tong; Qing Xu; Yi Xiao; Aiwen Wu; Yuan-Guang Chen; Bo Feng; Zhanlong Shen; Liang Huang; Xingwei Zhang; Minhua Zheng; Jian-Ping Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-14

Review 7.  Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom.

Authors:  Sameh Hany Emile; F Borja de Lacy; Deborah Susan Keller; Beatriz Martin-Perez; Sadir Alrawi; Antonio M Lacy; Manish Chand
Journal:  World J Gastrointest Surg       Date:  2018-03-27

8.  Natural orifice transluminal endoscopic surgery for colorectal cancer.

Authors:  P N Hiep; H H Thien; P A Vu; P H Thanh; N T Xuan
Journal:  BJS Open       Date:  2017-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.